154 related articles for article (PubMed ID: 38260739)
1. Targeted delivery of miR-34a-5p by phenylborate-coupled polyethylenimide nanocarriers for anti-KSHV treatment.
Li F; Cao D; Yao L; Gu W; Liu Z; Li D; Cui L
Front Bioeng Biotechnol; 2023; 11():1343956. PubMed ID: 38260739
[TBL] [Abstract][Full Text] [Related]
2. Folate-Targeted Nanocarriers Co-Deliver Ganciclovir and miR-34a-5p for Combined Anti-KSHV Therapy.
Li F; Cao D; Gu W; Li D; Liu Z; Cui L
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474177
[TBL] [Abstract][Full Text] [Related]
3. miR-34a-5p inhibits the malignant progression of KSHV-infected SH-SY5Y cells by targeting c-fos.
Wu S; Wu Z; Xu H; Zhang J; Gu W; Tan X; Pan Z; Cao D; Li D; Yang L; Li D; Pan Y
PeerJ; 2022; 10():e13233. PubMed ID: 35444864
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 Vpr Inhibits Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication by Inducing MicroRNA miR-942-5p and Activating NF-κB Signaling.
Yan Q; Shen C; Qin J; Li W; Hu M; Lu H; Qin D; Zhu J; Gao SJ; Lu C
J Virol; 2016 Oct; 90(19):8739-53. PubMed ID: 27440900
[TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.
Ramalingam D; Happel C; Ziegelbauer JM
J Virol; 2015 Apr; 89(8):4249-61. PubMed ID: 25631082
[TBL] [Abstract][Full Text] [Related]
6. kshv-mir-k12-1-5p promotes cell growth and metastasis by targeting SOCS6 in Kaposi's sarcoma cells.
Zhang J; Pu XM; Xiong Y
Cancer Manag Res; 2019; 11():4985-4995. PubMed ID: 31213914
[No Abstract] [Full Text] [Related]
7. Upregulation of MicroRNA 711 Mediates HIV-1 Vpr Promotion of Kaposi's Sarcoma-Associated Herpesvirus Latency and Induction of Pro-proliferation and Pro-survival Cytokines by Targeting the Notch/NF-κB-Signaling Axis.
Yan Q; Zhao R; Shen C; Wang F; Li W; Gao SJ; Lu C
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976660
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's Sarcoma-Associated Herpesvirus MicroRNAs Target GADD45B To Protect Infected Cells from Cell Cycle Arrest and Apoptosis.
Liu X; Happel C; Ziegelbauer JM
J Virol; 2017 Feb; 91(3):. PubMed ID: 27852859
[TBL] [Abstract][Full Text] [Related]
9. A Kaposi's sarcoma-associated herpes virus-encoded microRNA contributes to dilated cardiomyopathy.
Zhao Y; Li H; Du H; Yin Z; He M; Fan J; Nie X; Sun Y; Hou H; Dai B; Zhang X; Cai Y; Jin K; Ding N; Wen Z; Chang J; Chen C; Wang DW
Signal Transduct Target Ther; 2023 Jun; 8(1):226. PubMed ID: 37291118
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a promotes genomic instability by a broad suppression of genome maintenance mechanisms downstream of the oncogene KSHV-vGPCR.
Krause CJ; Popp O; Thirunarayanan N; Dittmar G; Lipp M; Müller G
Oncotarget; 2016 Mar; 7(9):10414-32. PubMed ID: 26871287
[TBL] [Abstract][Full Text] [Related]
11. A viral microRNA downregulates metastasis suppressor CD82 and induces cell invasion and angiogenesis by activating the c-Met signaling.
Li W; Hu M; Wang C; Lu H; Chen F; Xu J; Shang Y; Wang F; Qin J; Yan Q; Krueger BJ; Renne R; Gao SJ; Lu C
Oncogene; 2017 Sep; 36(38):5407-5420. PubMed ID: 28534512
[TBL] [Abstract][Full Text] [Related]
12. Bone targeted miRNA delivery system for miR-34a with enhanced anti-tumor efficacy to bone-associated metastatic breast cancer.
Han TY; Hou LS; Li JX; Huan ML; Zhou SY; Zhang BL
Int J Pharm; 2023 Mar; 635():122755. PubMed ID: 36801480
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of cell proliferation and migration by chondroitin sulfate-g-polyethylenimine-mediated miR-34a delivery.
Liang S; Duan Y; Xing Z; Han H; Zhang A; Li L; Yang Y; Li Q
Colloids Surf B Biointerfaces; 2015 Dec; 136():577-84. PubMed ID: 26454548
[TBL] [Abstract][Full Text] [Related]
14. Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts.
Xu J; Zhang G; Luo X; Wang D; Zhou W; Zhang Y; Zhang W; Chen J; Meng Q; Chen E; Chen H; Song Z
Theranostics; 2021; 11(5):2475-2489. PubMed ID: 33500737
[No Abstract] [Full Text] [Related]
15. Comparison of Peptide- and Lipid-Based Delivery of miR-34a-5p Mimic into PPC-1 Cells.
Urgard E; Brjalin A; Langel Ü; Pooga M; Rebane A; Annilo T
Nucleic Acid Ther; 2017 Oct; 27(5):295-302. PubMed ID: 28657476
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic KSHV-encoded interferon regulatory factor upregulates HMGB2 and CMPK1 expression to promote cell invasion by disrupting a complex lncRNA-OIP5-AS1/miR-218-5p network.
Li W; Wang Q; Feng Q; Wang F; Yan Q; Gao SJ; Lu C
PLoS Pathog; 2019 Jan; 15(1):e1007578. PubMed ID: 30699189
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Kaposi's sarcoma-associated herpesvirus lytic replication by HIV-1 Nef and cellular microRNA hsa-miR-1258.
Yan Q; Ma X; Shen C; Cao X; Feng N; Qin D; Zeng Y; Zhu J; Gao SJ; Lu C
J Virol; 2014 May; 88(9):4987-5000. PubMed ID: 24554664
[TBL] [Abstract][Full Text] [Related]
18. The Optimal Outcome of Suppressing Ewing Sarcoma Growth
Li DF; Yuan Y; Tu MJ; Hu X; Li YZ; Yi WR; Li PC; Zhao Y; Cheng Z; Yu AM; Jian C; Yu AX
Front Oncol; 2020; 10():222. PubMed ID: 32161722
[TBL] [Abstract][Full Text] [Related]
19. Baicalin-modified polyethylenimine for miR-34a efficient and safe delivery.
Wang Y; Wang B; Xiao Y; Cai Q; Xing J; Tang H; Li R; Zhang H
Front Bioeng Biotechnol; 2023; 11():1290413. PubMed ID: 38026879
[TBL] [Abstract][Full Text] [Related]
20. miR-769-3p inhibits cellular proliferation of KSHV-infected SH-SY5Y cells through targeting mTOR.
Cao D; Wu Z; Yang R; Yao L; Huang J; Ding Y; Ruzi A; Pan Z; Pan Y; Li D; Gu W; Zhang J
J Cancer; 2024; 15(11):3338-3349. PubMed ID: 38817860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
